Repositorio Dspace

Development of the ESEx index: a tool for predicting risk of recurrent severe COPD exacerbations

Mostrar el registro sencillo del ítem

dc.contributor.author Valera-Novella, Elisa
dc.contributor.author Bernabeu-Mora, Roberto
dc.contributor.author Montilla-Herrador, Joaquina
dc.contributor.author Escolar-Reina, Pilar
dc.contributor.author García-Vidal, José-Antonio
dc.contributor.author Medina-Mirapeix, Francesc
dc.date.accessioned 2025-11-20T07:25:18Z
dc.date.available 2025-11-20T07:25:18Z
dc.date.issued 2023
dc.identifier.citation Valera-Novella E, Bernabeu-Mora R, Montilla-Herrador J, Escolar-Reina P, García-Vidal JA, Medina-Mirapeix F. Development of the ESEx index: a tool for predicting risk of recurrent severe COPD exacerbations. Therapeutic Advances in Chronic Disease. enero de 2023;14:20406223231155115.
dc.identifier.issn 2040-6223
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21577
dc.description.abstract BACKGROUND: In chronic obstructive pulmonary disease (COPD), multiple recurrent severe exacerbations that require hospitalization can occur. These events are strongly associated with death and other clinical complications. OBJECTIVES: We aimed to develop a prognostic model that could identify patients with COPD that are at risk of multiple recurrent severe exacerbations within 3 years. DESIGN: Prospective cohort. METHODS: The derivation cohort comprised patients with stable, moderate-to-severe COPD. Multivariable logistic regression analyses were performed to develop the final model. Based on regression coefficients, a simplified index (ESEx) was established. Both, model and index, were assessed for predictive performance by measuring discrimination and calibration. RESULTS: Over 3 years, 16.4% of patients with COPD experienced at least three severe recurrent exacerbations. The prognostic model showed good discrimination of high-risk patients, based on three characteristics: the number of severe exacerbations in the previous year, performance in the five-repetition sit-to-stand test, and in the 6-minute-walk test. The ESEx index provided good level of discrimination [areas under the receiver operating characteristic curve (AUCs): 0.913]. CONCLUSIONS: The ESEx index showed good internal validation for the identification of patients at risk of three recurrent severe COPD exacerbations within 3 years. These tools could be used to identify patients who require early interventions and motivate patients to improve physical performance to prevent recurrent exacerbations.
dc.language.iso eng
dc.publisher SAGE PUBLICATIONS LTD
dc.rights http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.rights.uri Atribución-NoComercial-SinDerivadas 3.0 España *
dc.title Development of the ESEx index: a tool for predicting risk of recurrent severe COPD exacerbations
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 38405221
dc.relation.publisherversion https://journals.sagepub.com/doi/10.1177/20406223231155115
dc.identifier.doi 10.1177/20406223231155115
dc.journal.title Therapeutic Advances in Chronic Disease
dc.identifier.essn 2040-6231


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta